A prospective randomized trial to evaluate different oral dose regimens of medroxyprogesterone acetate in women with advanced breast cancer-Reference-Cited by-同舟云学术

A prospective randomized trial to evaluate different oral dose regimens of medroxyprogesterone acetate in women with advanced breast cancer

Published:1995-01 Issue:4 Volume:7 Page:251-256
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Clinton O.P.,Priestman T.J.,Latief T.N.,Earl H.,Murphy A.,Blackledge G.R.P.,Dunn J.,Baker P.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference18 articles.

1. Progestins 1: Medroxyprogesterone acetate;Pannuti,1991

2. An evaluation of high-dose medroxyprogesterone acetate (MPA) therapy in women with advanced breast cancer;Johnson;Br J Cancer,1984

3. Schulz K-D, Schmidt-Rhode P, Sturm G. High-dose medroxyprogesterone acetate in breast cancer: Present state of knowledge. In: Robustelli Delia Cuna G, et al., editors. Proceedings of the German-Italian Oncological Symposium; Freiburg: Kehrer Verlag KG: 21.

4. Pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate in advanced breast cancer patients;Etienne;J Clin Oncol,1992

5. High-dose progestin therapy for metastatic breast cancer;Muss;Ann Oncol,1992

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disparities in the survival improvement of recurrent breast cancer;Breast Cancer;2009-04-07

2. High-Dose Oral Medroxyprogesterone Acetate or Tamoxifen as Adjuvant Hormone Therapy for Node-Negative Early-Stage Breast Cancer: Randomized Trial with 7-Year Update;Clinical Breast Cancer;2004-06

3. Megestrol acetate in pediatric oncology patients may lead to severe, symptomatic adrenal suppression;Cancer;2003-07-02

4. Megestrol acetate therapy and secondary adrenal suppression;CANCER;1999

5. Megestrol acetate therapy and secondary adrenal suppression;Cancer;1999-09-15